VBI Vaccines Inc.. (VBIV) NASDAQ
$0.60 - (-)
Market Cap: $17.14M
As of 04/22/24 12:00 AM EDT. Market open.
VBI Vaccines Inc.. (VBIV)
NASDAQ
$0.60
- (-)
Market Cap: $17.14M
As of 04/22/24 12:00 AM EDT. Market open.
Add to Portfolio
vbi vaccines inc. (nasdaq: vbiv) is a biopharmaceutical company developing novel technologies that seek to expand vaccine protection in large underserved markets. vbi’s evlp vaccine platform allows for the design of enveloped (“e”) virus-like particle (“vlp”) vaccines that closely mimic the target virus. the company’s lead evlp asset is a prophylactic cytomegalovirus (cmv) vaccine; ... read more
COMPANY PROFILE
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
URL
Address
.
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
Full Time Employees
98
CEO Compensation (Base)
$465,000
URL
Address
.
PRICE CHART FOR VBI VACCINES INC.
From:
To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
-
Previous Close
$0.60
Days Range
$0.59 - $0.66
52 week range
$0.45 - $3.47
Volume
6,388
Avg. Volume (30 days)
1,165,667
Market Cap
$17.14M
Dividend Yield
-
P/E
(0.18)
Shares Outstanding
28,432,275
Open
-
Previous Close
$0.60
Days Range
$0.59 - $0.66
52 week range
$0.45 - $3.47
Volume
6,388
Avg. Volume (30 days)
1,165,667
Market Cap
$17.14M
Dividend Yield
-
P/E
(0.18)
Shares Outstanding
28,432,275
FINANCIAL STATEMENTS FOR VBI VACCINES INC.
LOADING...
INSIDER TRANSACTIONS FOR VBI VACCINES INC.
Owner | Relationship | Date | Transaction | Cost | # Shares | Value($) | Total Shares | Form 4 |
GILLIS STEVEN | Director | Jul 10, 2023 | Buy | $1.65 | 609,090 | 1,004,998 | 1,043,292 | Jul 18, 2023, 09:00 AM |
PERCEPTIVE ADVISORS LLC | 10% Owner | Apr 06, 2023 | Sale | $0.11 | 4,251,563 | 467,672 | 41,440,729 | Apr 06, 2023, 05:51 PM |
PERCEPTIVE ADVISORS LLC | 10% Owner | Apr 05, 2023 | Sale | $0.13 | 1,832,563 | 238,233 | 45,691,816 | Apr 06, 2023, 05:51 PM |
PERCEPTIVE ADVISORS LLC | 10% Owner | Apr 04, 2023 | Sale | $0.16 | 4,810,623 | 769,700 | 47,524,379 | Apr 06, 2023, 05:51 PM |
Beattie Nell | Chief Business Officer | Dec 03, 2021 | Buy | $2.45 | 8,200 | 20,083 | 68,200 | Dec 06, 2021, 10:06 AM |
PERCEPTIVE ADVISORS LLC | 10% Owner | Dec 01, 2021 | Sale | $3.31 | 2,707,463 | 8,961,702 | 52,334,993 | Dec 03, 2021, 06:22 PM |
PERCEPTIVE ADVISORS LLC | 10% Owner | Jun 29, 2021 | Sale | $3.80 | 646,257 | 2,455,777 | 0 | Jun 30, 2021, 04:40 PM |
PERCEPTIVE ADVISORS LLC | 10% Owner | Apr 24, 2020 | Buy | $1.10 | 9,090,909 | 10,000,000 | 55,042,456 | Apr 28, 2020, 09:00 AM |
Diaz-Mitoma Francisco | Chief Medical Officer | Oct 04, 2019 | Buy | $0.50 | 40,000 | 20,000 | 117,500 | Oct 07, 2019, 11:35 AM |
Diaz-Mitoma Francisco | Chief Medical Officer | Sep 30, 2019 | Buy | $0.50 | 14,500 | 7,250 | 14,500 | Oct 07, 2019, 11:35 AM |
McNulty Christopher | CFO and Head of BD | Oct 01, 2019 | Buy | $0.47 | 12,000 | 5,676 | 37,000 | Oct 01, 2019, 12:39 PM |
Beattie Nell | Chief Business Officer | Oct 01, 2019 | Buy | $0.48 | 10,000 | 4,822 | 60,000 | Oct 01, 2019, 12:39 PM |
Baxter Jeff | CEO, President | Sep 30, 2019 | Buy | $0.50 | 150,000 | 75,450 | 608,255 | Sep 30, 2019, 04:22 PM |
PERCEPTIVE ADVISORS LLC | 10% Owner | Sep 23, 2019 | Buy | $0.50 | 20,000,000 | 10,000,000 | 45,951,556 | Sep 24, 2019, 06:30 PM |
Diaz-Mitoma Francisco | Chief Medical Officer | Jun 27, 2019 | Buy | $1.07 | 8,000 | 8,560 | 77,500 | Jul 01, 2019, 06:10 AM |
Diaz-Mitoma Francisco | Chief Medical Officer | Jun 20, 2019 | Buy | $0.87 | 52,000 | 45,180 | 69,500 | Jun 20, 2019, 03:59 PM |
PERCEPTIVE ADVISORS LLC | 10% Owner | Jun 18, 2019 | Buy | $0.65 | 1,000,000 | 650,000 | 25,951,556 | Jun 20, 2019, 10:19 AM |
Beattie Nell | Chief Business Officer | Jun 19, 2019 | Buy | $0.74 | 8,000 | 5,886 | 50,000 | Jun 19, 2019, 12:20 PM |
Baxter Jeff | CEO, President | Jun 19, 2019 | Buy | $0.73 | 144,000 | 105,336 | 458,255 | Jun 19, 2019, 12:17 PM |
PERCEPTIVE ADVISORS LLC | 10% Owner | Jun 17, 2019 | Buy | $0.62 | 1,000,000 | 618,000 | 24,951,556 | Jun 18, 2019, 11:10 AM |
Kariv Tomer | Director | Dec 17, 2018 | Buy | $1.40 | 185,714 | 260,000 | 185,714 | Dec 18, 2018, 12:10 PM |
Kariv Tomer | Director | Dec 17, 2018 | Buy | $1.40 | 331,429 | 464,001 | 943,451 | Dec 18, 2018, 12:10 PM |
Kariv Tomer | Director | Dec 17, 2018 | Buy | $1.40 | 298,431 | 417,803 | 849,520 | Dec 18, 2018, 12:10 PM |
Kariv Tomer | Director | Dec 17, 2018 | Buy | $1.40 | 612,997 | 858,196 | 1,744,969 | Dec 18, 2018, 12:10 PM |
PERCEPTIVE ADVISORS LLC | 10% Owner | Dec 13, 2018 | Buy | $1.40 | 14,285,714 | 19,999,999 | 23,631,439 | Dec 17, 2018, 09:02 AM |
Baxter Jeff | CEO, President | Aug 06, 2018 | Buy | $1.93 | 8,100 | 15,607 | 233,005 | Aug 07, 2018, 08:38 PM |
Diaz-Mitoma Francisco | Chief Medical Officer | Aug 03, 2018 | Buy | $2.10 | 6,000 | 12,600 | 17,500 | Aug 06, 2018, 02:37 PM |
Diaz-Mitoma Francisco | Chief Medical Officer | Aug 02, 2018 | Buy | $2.20 | 3,000 | 6,600 | 11,500 | Aug 06, 2018, 02:37 PM |
Baxter Jeff | CEO, President | Aug 03, 2018 | Buy | $2.01 | 13,500 | 27,111 | 224,905 | Aug 06, 2018, 11:06 AM |
Beattie Nell | Chief Business Officer | Aug 03, 2018 | Buy | $2.01 | 2,000 | 4,011 | 20,750 | Aug 03, 2018, 03:21 PM |
Baxter Jeff | CEO, President | Jul 31, 2018 | Buy | $2.28 | 16,800 | 38,237 | 211,405 | Aug 01, 2018, 01:39 PM |
Anderson David Evander | Chief Scientific Officer | Jun 14, 2018 | Option Exercise | $3.76 | 9,281 | 34,897 | 101,334 | Jul 03, 2018, 03:34 PM |
Anderson David Evander | Chief Scientific Officer | Jun 14, 2018 | Option Exercise | $3.76 | 9,306 | 34,991 | 101,309 | Jun 18, 2018, 10:47 AM |
Baxter Jeff | CEO, President | May 24, 2018 | Buy | $2.99 | 11,000 | 32,890 | 163,355 | May 25, 2018, 01:54 PM |
Diaz-Mitoma Francisco | Chief Medical Officer | May 11, 2018 | Buy | $3.13 | 4,500 | 14,085 | 268,839 | May 14, 2018, 04:56 PM |
Diaz-Mitoma Francisco | Chief Medical Officer | May 11, 2018 | Buy | $2.98 | 5,500 | 16,390 | 8,500 | May 14, 2018, 04:56 PM |
Baxter Jeff | CEO, President | May 11, 2018 | Buy | $2.91 | 7,100 | 20,661 | 152,355 | May 14, 2018, 04:54 PM |
Baxter Jeff | CEO, President | Dec 12, 2017 | Buy | $3.89 | 10,000 | 38,854 | 145,255 | Dec 13, 2017, 05:21 PM |
Baxter Jeff | CEO, President | Nov 28, 2017 | Buy | $4.75 | 15,000 | 71,250 | 135,255 | Nov 29, 2017, 02:31 PM |
Opko Health, Inc. | 10% Owner | Oct 30, 2017 | Buy | $3.05 | 655,738 | 2,000,001 | 6,678,752 | Nov 01, 2017, 04:11 PM |
GILLIS STEVEN | Director | Oct 30, 2017 | Buy | $3.05 | 300,000 | 915,000 | 3,026,057 | Oct 31, 2017, 08:07 PM |
CHAWLA SAM | Director | Oct 30, 2017 | Buy | $3.05 | 3,100,000 | 9,455,000 | 9,345,725 | Oct 31, 2017, 08:05 PM |
PERCEPTIVE ADVISORS LLC | 10% Owner | Oct 26, 2017 | Buy | $3.05 | 3,100,000 | 9,455,000 | 9,345,725 | Oct 30, 2017, 04:11 PM |
Diaz-Mitoma Francisco | Chief Medical Officer | Aug 21, 2017 | Buy | $3.17 | 3,000 | 9,510 | 3,000 | Aug 22, 2017, 04:28 PM |
Baxter Jeff | CEO, President | Aug 21, 2017 | Buy | $3.22 | 10,000 | 32,200 | 120,255 | Aug 22, 2017, 04:20 PM |
Baxter Jeff | CEO, President | Aug 10, 2017 | Buy | $3.28 | 10,000 | 32,800 | 110,255 | Aug 14, 2017, 04:42 PM |
GILLIS STEVEN | Director | Jan 17, 2017 | Option Exercise | $2.50 | 6,377 | 15,943 | 28,166 | Mar 31, 2017, 08:20 PM |
Load More Insider Transactions
Buy
Sale
Option Exercise
Owner | Relationship | Date | Value($) |
GILLIS STEVEN | Director | 07/10/2023 | 1,004,998 |
PERCEPTIVE ADVISORS LLC | 10% Owner | 04/06/2023 | 467,672 |
PERCEPTIVE ADVISORS LLC | 10% Owner | 04/05/2023 | 238,233 |
PERCEPTIVE ADVISORS LLC | 10% Owner | 04/04/2023 | 769,700 |
Beattie Nell | Chief Business Officer | 12/03/2021 | 20,083 |
PERCEPTIVE ADVISORS LLC | 10% Owner | 12/01/2021 | 8,961,702 |
PERCEPTIVE ADVISORS LLC | 10% Owner | 06/29/2021 | 2,455,777 |
PERCEPTIVE ADVISORS LLC | 10% Owner | 04/24/2020 | 10,000,000 |
Diaz-Mitoma Francisco | Chief Medical Officer | 10/04/2019 | 20,000 |
Diaz-Mitoma Francisco | Chief Medical Officer | 09/30/2019 | 7,250 |
McNulty Christopher | CFO and Head of BD | 10/01/2019 | 5,676 |
Beattie Nell | Chief Business Officer | 10/01/2019 | 4,822 |
Baxter Jeff | CEO, President | 09/30/2019 | 75,450 |
PERCEPTIVE ADVISORS LLC | 10% Owner | 09/23/2019 | 10,000,000 |
Diaz-Mitoma Francisco | Chief Medical Officer | 06/27/2019 | 8,560 |
Diaz-Mitoma Francisco | Chief Medical Officer | 06/20/2019 | 45,180 |
PERCEPTIVE ADVISORS LLC | 10% Owner | 06/18/2019 | 650,000 |
Beattie Nell | Chief Business Officer | 06/19/2019 | 5,886 |
Baxter Jeff | CEO, President | 06/19/2019 | 105,336 |
PERCEPTIVE ADVISORS LLC | 10% Owner | 06/17/2019 | 618,000 |
Kariv Tomer | Director | 12/17/2018 | 260,000 |
Kariv Tomer | Director | 12/17/2018 | 464,001 |
Kariv Tomer | Director | 12/17/2018 | 417,803 |
Kariv Tomer | Director | 12/17/2018 | 858,196 |
PERCEPTIVE ADVISORS LLC | 10% Owner | 12/13/2018 | 19,999,999 |
Baxter Jeff | CEO, President | 08/06/2018 | 15,607 |
Diaz-Mitoma Francisco | Chief Medical Officer | 08/03/2018 | 12,600 |
Diaz-Mitoma Francisco | Chief Medical Officer | 08/02/2018 | 6,600 |
Baxter Jeff | CEO, President | 08/03/2018 | 27,111 |
Beattie Nell | Chief Business Officer | 08/03/2018 | 4,011 |
Baxter Jeff | CEO, President | 07/31/2018 | 38,237 |
Anderson David Evander | Chief Scientific Officer | 06/14/2018 | 34,897 |
Anderson David Evander | Chief Scientific Officer | 06/14/2018 | 34,991 |
Baxter Jeff | CEO, President | 05/24/2018 | 32,890 |
Diaz-Mitoma Francisco | Chief Medical Officer | 05/11/2018 | 14,085 |
Diaz-Mitoma Francisco | Chief Medical Officer | 05/11/2018 | 16,390 |
Baxter Jeff | CEO, President | 05/11/2018 | 20,661 |
Baxter Jeff | CEO, President | 12/12/2017 | 38,854 |
Baxter Jeff | CEO, President | 11/28/2017 | 71,250 |
Opko Health, Inc. | 10% Owner | 10/30/2017 | 2,000,001 |
GILLIS STEVEN | Director | 10/30/2017 | 915,000 |
CHAWLA SAM | Director | 10/30/2017 | 9,455,000 |
PERCEPTIVE ADVISORS LLC | 10% Owner | 10/26/2017 | 9,455,000 |
Diaz-Mitoma Francisco | Chief Medical Officer | 08/21/2017 | 9,510 |
Baxter Jeff | CEO, President | 08/21/2017 | 32,200 |
Baxter Jeff | CEO, President | 08/10/2017 | 32,800 |
GILLIS STEVEN | Director | 01/17/2017 | 15,943 |
Load More Insider Transactions
FUNDS WITH A POSITION IN VBI VACCINES INC.
Fund | # Shares Owned | % of Portfolio | % Change | Investing Style |
---|---|---|---|---|
GEODE CAPITAL MANAGEMENT, LLC | 138,729 | 0.00001% | No change | Other |
BLACKROCK INC. | 111,960 | 0% | No change | Other |
RENAISSANCE TECHNOLOGIES LLC | 66,842 | 0.00006% | 144.47% | Other |
ALPINE GLOBAL MANAGEMENT, LLC | 25,000 | 0.0047% | No change | Event Driven |
CHANGE IN SHARES OUTSTANDING FOR VBI VACCINES INC.
STOCK BUYBACKS FOR VBI VACCINES INC.
Load More
Period of Report: 12/31/2023
10-K/10-Q Filings: View
Previous Period
% Change in Shares
Quarter
09/30/2022
80.90%
5Q
06/30/2022
80.90%
6Q
03/31/2022
80.90%
7Q
12/31/2021
81.34%
8Q
09/30/2021
82.24%
9Q
06/30/2021
83.11%
10Q
03/31/2021
85.91%
11Q
Load More
BUYBACK ANNOUNCEMENT(S) FOR VBI VACCINES INC.
LOADING...